What is International Biotechnology Trust Net Margin %?
International Biotechnology TrustLSE:IBT +1.94%32 Net Margin % is 99.64% as of Feb. 2026, which is 2% above its 10-year median of 97.70. GuruFocus rates LSE:IBT with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, International Biotechnology Trust ranks better than 97.57% on this metric.
The historical rank and industry rank for International Biotechnology Trust's Net Margin % or its related term are showing as below:
LSE:IBT'
s Net Margin % Range Over the Past 10 Years
Min: 80.21 Med: 97.7 Max: 668.57
Current: 99
LSE:IBT's Net Margin % is ranked better than 97.57% of 947
companies
in the Biotechnology industry
Industry Median: -89.33
vs LSE:IBT: 99.00
International Biotechnology Trust (LSE:IBT) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
International Biotechnology Trust Net Margin % Related Terms
International Biotechnology Trust Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust Net Margin % Chart
LSE:IBT vs VRTX, REGN, ALNY: Net Margin % Comparison
For the Biotechnology subindustry, International Biotechnology Trust's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust Net Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Net Margin % distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust (LSE:IBT) has a Net Margin % of 99.64% as of Feb. 2026. Net margin is the ratio of total net income to net sales. View historical data on International Biotechnology Trust and its competitors. This is near median its historical median of 97.70. Over the past decade, International Biotechnology Trust's Net Margin % has ranged from 80.21 to 668.57. According to the industry distribution chart, International Biotechnology Trust ranks #23 out of 947 companies in the Biotechnology industry, placing it in the top 2.4%.
Is International Biotechnology Trust's Net Margin % too high?
International Biotechnology Trust's current Net Margin % of 99.64% is near median its 10-year median of 97.70. Over the past 10 years, this metric has ranged from a low of 80.21 to a high of 668.57. Based on the distribution chart, International Biotechnology Trust ranks #23 out of 947 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, International Biotechnology Trust has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #23 out of 947 companies for Net Margin %. This places International Biotechnology Trust in the top 2% of its industry — outperforming the majority of peers. Historically, International Biotechnology Trust's own Net Margin % has ranged from 80.21 to 668.57 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on International Biotechnology Trust and its competitors. International Biotechnology Trust's current Net Margin % is 99.64%, which is near median its own 10-year median of 97.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current Net Margin % of 99.64%. The current Net Margin % is 99.64%, which is near median its 10-year median of 97.70. International Biotechnology Trust's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current Net Margin % is 99.64% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
32GF Score
Get the complete analysis for LSE:IBT
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
